Basit öğe kaydını göster

dc.contributor.authorCirakoglu, Ayse
dc.contributor.authorUre, Umit
dc.contributor.authorCetin, Gueven
dc.contributor.authorFerhanoglu, Burhan
dc.contributor.authorAydin, Yildiz
dc.contributor.authorOngoren, Seniz
dc.contributor.authorKuru, Dilhan
dc.contributor.authorBaslar, Zafer
dc.contributor.authorTarkan-Arguden, Yelda
dc.contributor.authorUlku, Birsen
dc.contributor.authorSoysal, Teoman
dc.contributor.authorTuzuner, Nuekhet
dc.contributor.authorHacihanefioglu, Seniha
dc.contributor.authorAr, M. Cem
dc.contributor.authorDeviren, Ayhan
dc.contributor.authorGuven, Guelguen S.
dc.contributor.authorYilmaz, Suekriye
dc.contributor.authorEskazan, Ahmet Emre
dc.date.accessioned2021-03-04T09:40:34Z
dc.date.available2021-03-04T09:40:34Z
dc.date.issued2009
dc.identifier.citationOngoren S., Tarkan-Arguden Y., Ar M. C. , Yilmaz S., Ure U., Kuru D., Eskazan A. E. , Guven G. S. , Cetin G., Cirakoglu A., et al., "Clonal Chromosomal Abnormalities in Philadelphia-Negative Cells and Their Clinical Significance in Patients with Chronic Myeloid Leukemia: Results of a Single Center", TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, cilt.29, sa.2, ss.321-330, 2009
dc.identifier.issn1300-0292
dc.identifier.othervv_1032021
dc.identifier.otherav_695cf262-26a5-449f-8089-b1bb99c3ab74
dc.identifier.urihttp://hdl.handle.net/20.500.12627/73013
dc.description.abstractObjective: Chronic myeloid leukaemia (CML) is a haematological disease characterised by the presence of reciprocal t(9;22) translocation, called Philadelphia (Ph) chromosome. Highly improved haematological and cytogenetic results were reported in patients with chronic phase CML after introduction of imatinib into the market. Recently a number of studies draw attention to the emergence of clonal chromosomal abnormalities (CCAs) in Ph (-) cells during cytogenetic follow-up of CML patients. The clinical significance ofthe CCAs has not yet been clearly defined. The present study aims to demonstrate the occurrence pattern of CCA in Ph (-) cells in our cohort of CML patients and to investigate the impact of CCAs on the course and prognosis of CML. Material and Methods: A total of 45 patients were evaluated. Thirty-five patients with clonal chromosomal abnormalities in Ph(-) cells constituted the first group (GI), which was compared to a second group (GII) of 10 patients with complete cytogenetic response but no CCAs in terms of survival and disease progression. Results: The most frequent CCAs were -21, -18 and -20, followed by -22, -10, -17 and -19. Trisomies of Y and 8 were seen in 2 patients. In 9 cases structural abnormalities, such as del(7)(q11), del(17)(q11q21) and different marker chromosomes were observed. There were no difference between the two groups in terms of survival and progression. Dysplasia to some extent seems to occur in both groups irrespective of presence or absence of CCAs. Conclusion: According to our results, there is no convincing evidence that CCAs can alter the natural course of CIVIL on imatinib. We suggest that, regular cytogenetic monitoring with classical cytogenetic analysis is essential for CML patients on tyrosine kinase inhibitors, however it would be advisable to confirm and follow the most frequently observed numerical abnormalities by FISH technique as well.
dc.language.isoeng
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectTemel Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleClonal Chromosomal Abnormalities in Philadelphia-Negative Cells and Their Clinical Significance in Patients with Chronic Myeloid Leukemia: Results of a Single Center
dc.typeMakale
dc.relation.journalTURKIYE KLINIKLERI TIP BILIMLERI DERGISI
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume29
dc.identifier.issue2
dc.identifier.startpage321
dc.identifier.endpage330
dc.contributor.firstauthorID43568


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster